Bush, Thomas
Jensen, William A.
Katsumoto, Tamiko R.
Article History
Received: 13 July 2022
Accepted: 12 October 2022
First Online: 21 October 2022
Declarations
:
: Not applicable.
: Not applicable, as no identifiable information is revealed in the publication.
: TRK reported receiving consulting fees from Genentech and Sonoma Biotherapeutics and research support from Sanofi and the Koret Foundation. TB and WJ declare that they have no competing interests to disclose.